Locally advanced untreated non small cell lung cancer

Drug	Drug Name	Drug Description
DB01248	Docetaxel	A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer.

Drug	Drug Name	Target	Type
DB01248	Docetaxel	Apoptosis regulator Bcl-2	target
DB01248	Docetaxel	Tubulin beta-1 chain	target
DB01248	Docetaxel	Cytochrome P450 3A4	enzyme
DB01248	Docetaxel	Cytochrome P450 3A5	enzyme
DB01248	Docetaxel	Cytochrome P450 3A7	enzyme
DB01248	Docetaxel	P-glycoprotein 1	transporter
DB01248	Docetaxel	Multidrug resistance-associated protein 7	transporter
DB01248	Docetaxel	Cytochrome P450 1B1	enzyme
DB01248	Docetaxel	Microtubule-associated protein 2	target
DB01248	Docetaxel	Microtubule-associated protein 4	target
DB01248	Docetaxel	Microtubule-associated protein tau	target
DB01248	Docetaxel	Solute carrier organic anion transporter family member 1B3	transporter
DB01248	Docetaxel	Solute carrier family 22 member 7	transporter
DB01248	Docetaxel	ATP-binding cassette sub-family G member 2	transporter
DB01248	Docetaxel	Canalicular multispecific organic anion transporter 1	transporter
DB01248	Docetaxel	Multidrug resistance-associated protein 1	transporter
DB01248	Docetaxel	Nuclear receptor subfamily 1 group I member 2	target

Drug	Drug Name	Phase	Status	Count